Memory Commons Logo

UVA School of Medicine


Improving Outcomes for an Aging Population: Alzheimer's Treatment in Long Term Care

CME Activity

Activity Details
Release Date: May 1, 2013

Expiration Date: May 1, 2014

Credit Types: CME/CECredit Amount:

  • 1.25 AMA PRA Category 1 Credits™
  • 1.1 ANCC contact hours
  • 1.0 AANP contact hour

Estimated Time for Completion: 75 minutes (including pre/post-test and evaluation)

Cost: There is no fee to participate in this activity

Alzheimer's blood test edges closer

By James GallagherHealth and science reporter, BBC News

Researchers believe they are closer to developing a blood test that could diagnose Alzheimer's.

There is no definitive test for the brain-wasting disease. Doctors rely on cognition tests and brain scans.

A technique published in the journal Genome Biology showed differences in the tiny fragments of genetic material floating in the blood could be used to identify patients.


Study to find possible Alzheimer’s breakthrough

Nightly News

A new study is underway involving drugs that may prevent Alzheimer’s. NBC’s Robert Bazell reports.

Read More

F.D.A. Plans Looser Rules on Approving Alzheimer’s Drugs


Published: March 13, 2013

The Food and Drug Administration plans to loosen the rules for approving new treatments for Alzheimer’s disease.

Drugs in clinical trial would qualify for approval if people at very early stages of the disease subtly improved their performance on memory or reasoning tests, even before they developed any obvious impairments. Companies would not have to show that the drugs improved daily, real-world functioning.

For more than a decade, the only way to get Alzheimer’s drugs to market was with studies showing that they improved the ability of patients not only to think and remember, but also to function day to day at activities like feeding, dressing or bathing themselves.

Read More

Nutritional Supplement May Help Prevent Alzheimer’s, U.Va. Research Suggests

JANUARY 9, 2013

A nutritional supplement available over-the-counter may offer protection from Alzheimer’s disease, a study by the University of Virginia and Northwestern University suggests.

Researchers at Northwestern and U.Va.’s School of Medicine set out to evaluate the effectiveness of chiro-inositol, a compound that occurs naturally in certain foods and is available as a nutritional supplement, in protecting the brain from beta amyloid toxins, which cause Alzheimer’s. They conclude, in a paper published this month in The FASEB Journal (link available on Grounds only), that chiro-inositol “greatly enhances” insulin’s ability to prevent damage to neurons by toxic peptides called ADDLs. The damage and loss of neurons is believed responsible for Alzheimer’s.


More Articles...

Page 1 of 14


Forgot login?
No account yet? Register

Where are we with biomarker diagnosis and other tests for Alzheimer's Disease?